BioSpace News Archive

Drug Development

Resverlogix Reports Positive FDA Type B Meeting On Design Issues Relating To A Proposed Phase IIa Kidney Dialysis Trial

February 23, 2017
·
4 min read
Drug Development

CBT Pharma Presents Data Demonstrating Anti-Tumor Activity Of Its Programmed Death-1 Antibody, CBT-501, At ASCO-SITC Clinical Oncology Symposium

February 23, 2017
·
3 min read
Drug Development

Tocagen Achieves Key Development Milestone For Lead Product: Phase II Randomized Trial In Patients With Recurrent Brain Cancer Fully Enrolled

February 23, 2017
·
4 min read
Nexstim Release: Final Results From NICHE Phase III Trial Presented At The International Stroke Conference

February 23, 2017
·
2 min read
Business

OncoGenex Reports Financial Results For Year End 2016

February 23, 2017
·
8 min read
Drug Development

Children’s National Health System Experts To Present Data On Novel Approach To Cell Therapy For Cancer Patients

February 23, 2017
·
4 min read
Policy

Pernix Prevails In Zohydro ER ANDA Litigation

February 23, 2017
·
2 min read
Drug Development

OncoSec Medical Announces Positive Phase II Data Demonstrating Company’s ImmunoPulse IL-12 In Combination With Pembrolizumab Increased Response Rates In Anti-PD-1 Non-Responder Melanoma Patients

February 23, 2017
·
7 min read
Pharm Country

Innophos Holdings, Inc. Declares Quarterly Dividend

February 23, 2017
·
1 min read
Pharm Country

Biotech Support Group Release: Research Article Cites Cleanascite For Bead-based Antibody Array Proteome Analysis Of Human Bile

February 23, 2017
·
2 min read